JPRN-UMIN000002073已完成2 期
Phase II study of combination therapy of cisplatin suspension in lipiodol and 5-fluorouracil hepatic arterial infusion for advanced HCC - The study of NFP for advanced HCC
Division of Gastroenterology,Kurume University School of Medicine0 个研究点目标入组 50 人开始时间: 2009年7月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
52 cases PFS=8.5 months MST=27 months Tumor Response response rate=75%
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 30years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.previous chemotherapy or TAE 2.Previous operation or RFA or PEIT within one year 3.Extrahepatic metastasis or nodes metastasis 4.Concurrent infections(without hepatitis virus) 5.Active double cancers 6.Medical history of severe hypersensitivity. 7.Pregnant,lacting women or women with suspected pregnancy. 8.Inappropriate patients for this study judged by physicians.
研究者
相似试验
Unknown
2 期
Cisplatin,Docetaxel and S-1 for Advanced Gastric and Gastroesophageal Junction CancerGastroesophageal Junction CancerGastric CancerNCT01747707Chinese Academy of Medical Sciences40
已完成
2 期
Clinical Trial of Chemotherapy Combination Cisplatin-Fluorouracil-Afatinib in Patients With Inoperable Gastric CancerGastric CancerGastroesophageal Junction CancerNCT01743365Hellenic Cooperative Oncology Group55
已完成
不适用
A phase II trial of S-1 plus cisplatin with concurrent proton therapy for locally advanced NSCLCunresectable stage III NSCLCJPRN-UMIN000036978agoya City West Medical Center41
已完成
2 期
Trial Evaluating Adapted Chemotherapy in Patients With Squamous CarcinomaCancer of Head and NeckNCT04356170Groupe Oncologie Radiotherapie Tete et Cou105
终止
1 期
Combination of Cisplatin, Cetuximab and Temsirolimus in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckSquamous Cell Carcinoma of the Head and NeckNCT01015664University of Tennessee Cancer Institute11